Volker Knappertz, EVP, Research and Development at Aurinia Pharmaceuticals Inc. (AUPH), sold 4,930 shares at $6.10 ($30K) on 2024-02-27, disclosed to the SEC on 2024-02-29.
Open-market sale of $30k AUPH by EVP, Research and Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| GWPH | SELL | 2021-01-20 | $70K | — | Filing → |
| GWPH | SELL | 2020-11-25 | $126K | — | Filing → |
| GWPH | SELL | 2020-11-13 | $60K | — | Filing → |